For tendonitis recovery in Canada, a common BPC-157 and TB-500 blend dosage is 250 mcg to 500 mcg of each peptide injected subcutaneously once or twice daily. This stack is widely used by athletes and researchers to accelerate tendon healing, reduce inflammation, and improve mobility. The exact dose depends on injury severity, body weight, and individual response.
Why Combine BPC-157 and TB-500 for Tendonitis?
BPC-157 is a synthetic peptide derived from a protein found in gastric juice. It promotes angiogenesis, the formation of new blood vessels, which speeds tissue repair. TB-500 is a fragment of thymosin beta-4, a protein that regulates actin, a key component of cell structure and movement. Together they work synergistically: BPC-157 drives local healing at the injury site, while TB-500 reduces systemic inflammation and improves cell migration.
For tendonitis, this combination addresses both the structural damage and the chronic inflammatory environment. Clinical and anecdotal evidence suggests faster pain relief and functional recovery compared to either peptide alone. Many Canadian researchers and biohackers source these peptides from domestic suppliers to avoid customs delays.
Standard BPC-157 TB-500 Blend Dosage Protocol
The most common protocol for tendonitis is 250 mcg of BPC-157 and 250 mcg of TB-500 injected once daily for 4 to 6 weeks. Some users split the dose into two injections of 125 mcg each, morning and evening, to maintain stable blood levels. For more severe or chronic tendonitis, the dose may be increased to 500 mcg of each peptide twice daily, but this is less common and should be approached cautiously.
Dosing is typically based on body weight. A general guideline is 2.5 to 3.5 mcg per kilogram of body weight for each peptide. For an 80 kg person, that equals 200 to 280 mcg per dose. However, most pre-mixed blends come in fixed ratios, such as 5 mg BPC-157 and 5 mg TB-500 per vial, which simplifies dosing.
To reconstitute a 5 mg/5 mg blend, add 2 mL of bacteriostatic water. Then each 0.1 mL contains 250 mcg of each peptide. A typical injection volume is 0.1 to 0.2 mL. Always use a new sterile syringe and alcohol swab. Rotate injection sites to avoid irritation.
Cycle Length and Timing for Tendonitis Recovery
A standard cycle lasts 4 to 6 weeks. Most users report noticeable improvement within 2 to 3 weeks, but full tendon remodeling takes longer. After a cycle, a 2 to 4 week break is recommended to prevent receptor desensitization. Some researchers run a second cycle if pain persists.
Injections are best done on an empty stomach, either first thing in the morning or before bed. Consistency matters more than exact timing. For localized tendonitis, some users inject near the injury site, but both peptides work systemically, so subcutaneous injection into the abdomen or thigh is equally effective.
Expected Results and Timeline
In published animal studies and anecdotal reports, BPC-157 and TB-500 reduce tendonitis pain within 7 to 14 days. Improved range of motion and reduced stiffness often follow by week 3. Full recovery depends on the tendon involved, age, and activity level. Achilles and patellar tendonitis may take 6 to 8 weeks of combined therapy plus physical rehabilitation.
One user with chronic elbow tendonitis reported a 70% pain reduction after 4 weeks on 250 mcg of each peptide daily. Another with rotator cuff tendonitis saw significant improvement after 6 weeks. These results align with the peptides' mechanisms: increased collagen synthesis, reduced oxidative stress, and faster fibroblast migration.
Where to Buy BPC-157 TB-500 Blend in Canada
In Canada, research peptides are legal for laboratory use but not for human consumption. Many Canadian vendors sell BPC-157 and TB-500 as individual vials or pre-mixed blends. Prices range from $40 to $80 CAD for a 5 mg vial of each peptide. A 5 mg/5 mg blend vial typically costs $60 to $100 CAD. Always verify third-party lab testing and read customer reviews before purchasing.
For a detailed comparison of BPC-157 and TB-500 for muscle recovery, see our article on choosing between BPC-157 and TB-500 in Quebec. If you are concerned about side effects, review our safety and side effects analysis. For weight-based dosing, use our BPC-157 TB-500 blend dosage calculator.
Safety and Side Effects
Both peptides have excellent safety profiles in animal studies. Reported side effects are mild and rare: temporary injection site redness, mild headache, or transient dizziness. No serious adverse events have been documented in human use at typical doses. However, long-term safety data is limited. Pregnant or nursing women, individuals with cancer, and those on blood thinners should avoid these peptides.
Because peptides are not approved by Health Canada for human use, users assume all risks. Always start with the lowest effective dose and monitor your body's response. If you experience persistent side effects, discontinue use and consult a healthcare professional.
Legal Status in Canada
In Canada, BPC-157 and TB-500 are not controlled substances. They fall under the category of research chemicals, which can be legally imported for laboratory purposes. However, selling them for human consumption is prohibited. This legal gray area means many Canadians buy from domestic suppliers who label products "for research only." Importing from international vendors carries a risk of customs seizure.
For more on the regulatory landscape, read our update on TB-500 availability in Canada.
Frequently Asked Questions
Can I inject BPC-157 and TB-500 together?
Yes, they can be mixed in the same syringe and injected subcutaneously. Many pre-mixed blends are available. If using separate vials, draw both peptides into one syringe. Ensure the total volume is comfortable, typically under 0.5 mL.
How long does a 5 mg/5 mg blend vial last?
At 250 mcg of each peptide daily, a 5 mg/5 mg vial lasts 20 days. At 500 mcg daily, it lasts 10 days. Reconstituted peptides should be refrigerated and used within 30 days for optimal stability.
Is a loading dose necessary?
No loading dose is required. Some users take a higher dose for the first 3 days, but this is not supported by evidence. A consistent daily dose is more important for steady tissue saturation.
Can I use this stack for other injuries?
Yes, BPC-157 and TB-500 are used for muscle tears, ligament sprains, and post-surgical recovery. The same dosage range applies. For muscle recovery specifically, see our before and after results article.
Final Thoughts on BPC-157 TB-500 for Tendonitis
The BPC-157 and TB-500 blend is a promising research stack for tendonitis recovery. A daily dose of 250 mcg of each peptide for 4 to 6 weeks is the most evidence-based protocol. Canadian users should source from reputable domestic vendors and adhere to research-only guidelines. Always combine peptide therapy with proper rest, physical therapy, and gradual return to activity for the best outcome.